Use of Glutamate modulating agents with Immunotherapies to treat cancer

• 收藏
• 分享

专利权人:

BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

发明人:

Coric, Vladimir

申请号：

AU2017266951

公开号：

AU2017266951A1

申请日:

2017.05.19

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Disclosed are methods of treating cancer using a combination of an immunotherapeutic agent, such as, for example, a PD-1, PD-L1 or CTLA-4 checkpoint inhibitor, and a glutamate modulating agent such as riluzole or trigriluzole. Pharmaceutical compositions and kits including the immunotherapeutic agents and glutamate modulating agents are also disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/